GLOBEALERT
BUSINESS● LOWOct 1 · Oct 1, 2026, 9:22 AM

Sanofi to pay Regeneron up to $8B to expand long-acting drug pipeline

Seeking Alpha Tech · global

Sanofi plans to pay Regeneron up to $8 billion to expand its long-acting drug pipeline. This significant financial agreement aims to boost Sanofi's pharmaceutical development capabilities.

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

More in Business

Sanofi to pay Regeneron up to $8B to expand long-acting drug pipeline · GlobeAlert